Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
-
TD Cowen Reiterates Hold Rating on Sanofi-Aventis (SNY) as 'Duvakitug Shows Strong Topline Data'
-
Horizon Therapeutics seen worth up to $140/share in takeover
-
Sanofi-Aventis (SNY) PT Raised to $53 at Cowen
-
German Court Ruling Positive for Amgen (AMGN), Negative for Regeneron (REGN) - Cowen
-
Sanofi-Aventis (SNY) PT Raised to $52 at Cowen; 'Q2 EPS Ahead of Forecast, 2017 Guidance Raised'
-
Emergent BioSolutions (EBS) to Acquire ACAM2000 Business From Sanofi (SNY) for $125M
-
Streetinsider.com's Hot Lunchtime Reads 10/4: (DPS) (SNI) (CRTO) (SNY)
-
Streetinsider.com's Hot Lunchtime Reads 3/3: (COST) (SSYS) (TUMI) (TOT)
-
Notable Analyst Rating Changes 10/15: (F) (SNY) (FB) Upgraded; (WMT) (SLH) (MHR) Downgraded
-
PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables
-
BioMarin to Present at the Cowen Healthcare Conference in Boston
-
Cowen Downgrades Sanofi (SNY) to Market Perform
-
Cowen Upgrades Sanofi-Aventis (SNY) to Outperform
-
Notable Analyst Rating Changes 6/10: YHOO, X, ZEUS, DB Upgraded; SINA, CRDN, FSLR, PLL Downgraded
-
Cowen & Co Initiates Coverage on Sanofi-Aventis (SNY) with a Neutral

